Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 153.24
+0.79 (0.52%)
Jan 28, 2026, 3:00 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 202.43 billion as of January 28, 2026. Its market cap has decreased by -39.05% in one year.
Market Cap
202.43B
Enterprise Value
243.50B
Revenue
89.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
153.24
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has decreased from 226.73B to 202.43B, a decrease of -10.72%. That is a compound annual growth rate of -3.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 202.43B | -11.47% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Laurus Labs | 548.71B |
| Ipca Laboratories | 371.12B |
| Ajanta Pharma | 337.15B |
| Emcure Pharmaceuticals | 290.20B |
| Gland Pharma | 277.20B |
| Wockhardt | 219.62B |
| Eris Lifesciences | 191.94B |
| Alembic Pharmaceuticals | 150.28B |